Industry Research Reports
Home > Reports > Chemical & Material > Global Valacyclovir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Valacyclovir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Chemical & Material
Published Date: 2025-11-09
Pages: 78 Pages
Report ld: 5403964
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Valacyclovir API market competitiveness, regional economic performance, and supply chain configurations.
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Valacyclovir API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Mylan
- NEWEDGE Overseas
- Aurore Life Sciences
- Arch Pharmalabs
- SMS Pharmaceuticals
- Exemed PharmaceuticalsFDAWHO-GMP
- Aurobindo Pharma LimitedFDAEDQMWHO-GMP
- Piramal Pharma Solutions
- Rajasthan Antibiotics
- Vital Laboratories Private Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Above 98 %
- Above 99 %
Segment by Application
- Tablets
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Valacyclovir API market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Above 99 % in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Others in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Valacyclovir API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Valacyclovir API Product Scope
1.2 Valacyclovir API by Type
1.2.1 Global Valacyclovir API Sales by Type (2020 & 2024 & 2031)
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Valacyclovir API by Application
1.3.1 Global Valacyclovir API Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Tablets
1.3.3 Others
1.4 Global Valacyclovir API Market Estimates and Forecasts (2020-2031)
1.4.1 Global Valacyclovir API Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Valacyclovir API Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Valacyclovir API Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Valacyclovir API Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Valacyclovir API Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Valacyclovir API Sales Market Share by Region (2020-2025)
2.2.2 Global Valacyclovir API Revenue Market Share by Region (2020-2025)
2.3 Global Valacyclovir API Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Valacyclovir API Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Valacyclovir API Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Valacyclovir API Market Size and Prospective (2020-2031)
2.4.2 Europe Valacyclovir API Market Size and Prospective (2020-2031)
2.4.3 China Valacyclovir API Market Size and Prospective (2020-2031)
2.4.4 Australia Valacyclovir API Market Size and Prospective (2020-2031)
2.4.5 Israel Valacyclovir API Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Valacyclovir API Historic Market Review by Type (2020-2025)
3.1.1 Global Valacyclovir API Sales by Type (2020-2025)
3.1.2 Global Valacyclovir API Revenue by Type (2020-2025)
3.1.3 Global Valacyclovir API Price by Type (2020-2025)
3.2 Global Valacyclovir API Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Valacyclovir API Sales Forecast by Type (2026-2031)
3.2.2 Global Valacyclovir API Revenue Forecast by Type (2026-2031)
3.2.3 Global Valacyclovir API Price Forecast by Type (2026-2031)
3.3 Different Types Valacyclovir API Representative Players
4 Global Market Size by Application
4.1 Global Valacyclovir API Historic Market Review by Application (2020-2025)
4.1.1 Global Valacyclovir API Sales by Application (2020-2025)
4.1.2 Global Valacyclovir API Revenue by Application (2020-2025)
4.1.3 Global Valacyclovir API Price by Application (2020-2025)
4.2 Global Valacyclovir API Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Valacyclovir API Sales Forecast by Application (2026-2031)
4.2.2 Global Valacyclovir API Revenue Forecast by Application (2026-2031)
4.2.3 Global Valacyclovir API Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Valacyclovir API Application
5 Competition Landscape by Players
5.1 Global Valacyclovir API Sales by Players (2020-2025)
5.2 Global Top Valacyclovir API Players by Revenue (2020-2025)
5.3 Global Valacyclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir API as of 2024)
5.4 Global Valacyclovir API Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Valacyclovir API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Valacyclovir API, Product Type & Application
5.7 Global Key Manufacturers of Valacyclovir API, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Valacyclovir API Sales by Company
6.1.1.1 North America Valacyclovir API Sales by Company (2020-2025)
6.1.1.2 North America Valacyclovir API Revenue by Company (2020-2025)
6.1.2 North America Valacyclovir API Sales Breakdown by Type (2020-2025)
6.1.3 North America Valacyclovir API Sales Breakdown by Application (2020-2025)
6.1.4 North America Valacyclovir API Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Valacyclovir API Sales by Company
6.2.1.1 Europe Valacyclovir API Sales by Company (2020-2025)
6.2.1.2 Europe Valacyclovir API Revenue by Company (2020-2025)
6.2.2 Europe Valacyclovir API Sales Breakdown by Type (2020-2025)
6.2.3 Europe Valacyclovir API Sales Breakdown by Application (2020-2025)
6.2.4 Europe Valacyclovir API Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Valacyclovir API Sales by Company
6.3.1.1 China Valacyclovir API Sales by Company (2020-2025)
6.3.1.2 China Valacyclovir API Revenue by Company (2020-2025)
6.3.2 China Valacyclovir API Sales Breakdown by Type (2020-2025)
6.3.3 China Valacyclovir API Sales Breakdown by Application (2020-2025)
6.3.4 China Valacyclovir API Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Australia Market: Players, Segments, Downstream and Major Customers
6.4.1 Australia Valacyclovir API Sales by Company
6.4.1.1 Australia Valacyclovir API Sales by Company (2020-2025)
6.4.1.2 Australia Valacyclovir API Revenue by Company (2020-2025)
6.4.2 Australia Valacyclovir API Sales Breakdown by Type (2020-2025)
6.4.3 Australia Valacyclovir API Sales Breakdown by Application (2020-2025)
6.4.4 Australia Valacyclovir API Major Customer
6.4.5 Australia Market Trend and Opportunities
6.5 Israel Market: Players, Segments, Downstream and Major Customers
6.5.1 Israel Valacyclovir API Sales by Company
6.5.1.1 Israel Valacyclovir API Sales by Company (2020-2025)
6.5.1.2 Israel Valacyclovir API Revenue by Company (2020-2025)
6.5.2 Israel Valacyclovir API Sales Breakdown by Type (2020-2025)
6.5.3 Israel Valacyclovir API Sales Breakdown by Application (2020-2025)
6.5.4 Israel Valacyclovir API Major Customer
6.5.5 Israel Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Mylan
7.1.1 Mylan Company Information
7.1.2 Mylan Business Overview
7.1.3 Mylan Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Mylan Valacyclovir API Products Offered
7.1.5 Mylan Recent Development
7.2 NEWEDGE Overseas
7.2.1 NEWEDGE Overseas Company Information
7.2.2 NEWEDGE Overseas Business Overview
7.2.3 NEWEDGE Overseas Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.2.4 NEWEDGE Overseas Valacyclovir API Products Offered
7.2.5 NEWEDGE Overseas Recent Development
7.3 Aurore Life Sciences
7.3.1 Aurore Life Sciences Company Information
7.3.2 Aurore Life Sciences Business Overview
7.3.3 Aurore Life Sciences Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Aurore Life Sciences Valacyclovir API Products Offered
7.3.5 Aurore Life Sciences Recent Development
7.4 Arch Pharmalabs
7.4.1 Arch Pharmalabs Company Information
7.4.2 Arch Pharmalabs Business Overview
7.4.3 Arch Pharmalabs Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Arch Pharmalabs Valacyclovir API Products Offered
7.4.5 Arch Pharmalabs Recent Development
7.5 SMS Pharmaceuticals
7.5.1 SMS Pharmaceuticals Company Information
7.5.2 SMS Pharmaceuticals Business Overview
7.5.3 SMS Pharmaceuticals Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.5.4 SMS Pharmaceuticals Valacyclovir API Products Offered
7.5.5 SMS Pharmaceuticals Recent Development
7.6 Exemed PharmaceuticalsFDAWHO-GMP
7.6.1 Exemed PharmaceuticalsFDAWHO-GMP Company Information
7.6.2 Exemed PharmaceuticalsFDAWHO-GMP Business Overview
7.6.3 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Products Offered
7.6.5 Exemed PharmaceuticalsFDAWHO-GMP Recent Development
7.7 Aurobindo Pharma LimitedFDAEDQMWHO-GMP
7.7.1 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Company Information
7.7.2 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Business Overview
7.7.3 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Products Offered
7.7.5 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Development
7.8 Piramal Pharma Solutions
7.8.1 Piramal Pharma Solutions Company Information
7.8.2 Piramal Pharma Solutions Business Overview
7.8.3 Piramal Pharma Solutions Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Piramal Pharma Solutions Valacyclovir API Products Offered
7.8.5 Piramal Pharma Solutions Recent Development
7.9 Rajasthan Antibiotics
7.9.1 Rajasthan Antibiotics Company Information
7.9.2 Rajasthan Antibiotics Business Overview
7.9.3 Rajasthan Antibiotics Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Rajasthan Antibiotics Valacyclovir API Products Offered
7.9.5 Rajasthan Antibiotics Recent Development
7.10 Vital Laboratories Private Limited
7.10.1 Vital Laboratories Private Limited Company Information
7.10.2 Vital Laboratories Private Limited Business Overview
7.10.3 Vital Laboratories Private Limited Valacyclovir API Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Vital Laboratories Private Limited Valacyclovir API Products Offered
7.10.5 Vital Laboratories Private Limited Recent Development
8 Valacyclovir API Manufacturing Cost Analysis
8.1 Valacyclovir API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Valacyclovir API
8.4 Valacyclovir API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Valacyclovir API Distributors List
9.3 Valacyclovir API Customers
10 Valacyclovir API Market Dynamics
10.1 Valacyclovir API Industry Trends
10.2 Valacyclovir API Market Drivers
10.3 Valacyclovir API Market Challenges
10.4 Valacyclovir API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Valacyclovir API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Valacyclovir API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Valacyclovir API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Valacyclovir API Sales (Kg) by Region (2020-2025)
Table 5. Global Valacyclovir API Sales Market Share by Region (2020-2025)
Table 6. Global Valacyclovir API Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Valacyclovir API Revenue Share by Region (2020-2025)
Table 8. Global Valacyclovir API Sales (Kg) Forecast by Region (2026-2031)
Table 9. Global Valacyclovir API Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Valacyclovir API Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Valacyclovir API Revenue Share Forecast by Region (2026-2031)
Table 12. Global Valacyclovir API Sales by Type (Kg) & (2020-2025)
Table 13. Global Valacyclovir API Sales Share by Type (2020-2025)
Table 14. Global Valacyclovir API Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Valacyclovir API Price by Type (US$/Kg) & (2020-2025)
Table 16. Global Valacyclovir API Sales by Type (Kg) & (2026-2031)
Table 17. Global Valacyclovir API Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Valacyclovir API Price by Type (US$/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Valacyclovir API Sales by Application (Kg) & (2020-2025)
Table 21. Global Valacyclovir API Sales Share by Application (2020-2025)
Table 22. Global Valacyclovir API Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Valacyclovir API Price by Application (US$/Kg) & (2020-2025)
Table 24. Global Valacyclovir API Sales by Application (Kg) & (2026-2031)
Table 25. Global Valacyclovir API Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Valacyclovir API Price by Application (US$/Kg) & (2026-2031)
Table 27. New Sources of Growth in Valacyclovir API Application
Table 28. Global Valacyclovir API Sales by Company (Kg) & (2020-2025)
Table 29. Global Valacyclovir API Sales Share by Company (2020-2025)
Table 30. Global Valacyclovir API Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Valacyclovir API Revenue Share by Company (2020-2025)
Table 32. Global Valacyclovir API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir API as of 2024)
Table 33. Global Market Valacyclovir API Average Price by Company (US$/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Valacyclovir API, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Valacyclovir API, Product Type & Application
Table 36. Global Key Manufacturers of Valacyclovir API, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Valacyclovir API Sales by Company (2020-2025) & (Kg)
Table 39. North America Valacyclovir API Sales Market Share by Company (2020-2025)
Table 40. North America Valacyclovir API Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Valacyclovir API Revenue Market Share by Company (2020-2025)
Table 42. North America Valacyclovir API Sales by Type (2020-2025) & (Kg)
Table 43. North America Valacyclovir API Sales Market Share by Type (2020-2025)
Table 44. North America Valacyclovir API Sales by Application (2020-2025) & (Kg)
Table 45. North America Valacyclovir API Sales Market Share by Application (2020-2025)
Table 46. Europe Valacyclovir API Sales by Company (2020-2025) & (Kg)
Table 47. Europe Valacyclovir API Sales Market Share by Company (2020-2025)
Table 48. Europe Valacyclovir API Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Valacyclovir API Revenue Market Share by Company (2020-2025)
Table 50. Europe Valacyclovir API Sales by Type (2020-2025) & (Kg)
Table 51. Europe Valacyclovir API Sales Market Share by Type (2020-2025)
Table 52. Europe Valacyclovir API Sales by Application (2020-2025) & (Kg)
Table 53. Europe Valacyclovir API Sales Market Share by Application (2020-2025)
Table 54. China Valacyclovir API Sales by Company (2020-2025) & (Kg)
Table 55. China Valacyclovir API Sales Market Share by Company (2020-2025)
Table 56. China Valacyclovir API Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Valacyclovir API Revenue Market Share by Company (2020-2025)
Table 58. China Valacyclovir API Sales by Type (2020-2025) & (Kg)
Table 59. China Valacyclovir API Sales Market Share by Type (2020-2025)
Table 60. China Valacyclovir API Sales by Application (2020-2025) & (Kg)
Table 61. China Valacyclovir API Sales Market Share by Application (2020-2025)
Table 62. Australia Valacyclovir API Sales by Company (2020-2025) & (Kg)
Table 63. Australia Valacyclovir API Sales Market Share by Company (2020-2025)
Table 64. Australia Valacyclovir API Revenue by Company (2020-2025) & (US$ Million)
Table 65. Australia Valacyclovir API Revenue Market Share by Company (2020-2025)
Table 66. Australia Valacyclovir API Sales by Type (2020-2025) & (Kg)
Table 67. Australia Valacyclovir API Sales Market Share by Type (2020-2025)
Table 68. Australia Valacyclovir API Sales by Application (2020-2025) & (Kg)
Table 69. Australia Valacyclovir API Sales Market Share by Application (2020-2025)
Table 70. Israel Valacyclovir API Sales by Company (2020-2025) & (Kg)
Table 71. Israel Valacyclovir API Sales Market Share by Company (2020-2025)
Table 72. Israel Valacyclovir API Revenue by Company (2020-2025) & (US$ Million)
Table 73. Israel Valacyclovir API Revenue Market Share by Company (2020-2025)
Table 74. Israel Valacyclovir API Sales by Type (2020-2025) & (Kg)
Table 75. Israel Valacyclovir API Sales Market Share by Type (2020-2025)
Table 76. Israel Valacyclovir API Sales by Application (2020-2025) & (Kg)
Table 77. Israel Valacyclovir API Sales Market Share by Application (2020-2025)
Table 78. Mylan Company Information
Table 79. Mylan Description and Business Overview
Table 80. Mylan Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 81. Mylan Valacyclovir API Product
Table 82. Mylan Recent Development
Table 83. NEWEDGE Overseas Company Information
Table 84. NEWEDGE Overseas Description and Business Overview
Table 85. NEWEDGE Overseas Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 86. NEWEDGE Overseas Valacyclovir API Product
Table 87. NEWEDGE Overseas Recent Development
Table 88. Aurore Life Sciences Company Information
Table 89. Aurore Life Sciences Description and Business Overview
Table 90. Aurore Life Sciences Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 91. Aurore Life Sciences Valacyclovir API Product
Table 92. Aurore Life Sciences Recent Development
Table 93. Arch Pharmalabs Company Information
Table 94. Arch Pharmalabs Description and Business Overview
Table 95. Arch Pharmalabs Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 96. Arch Pharmalabs Valacyclovir API Product
Table 97. Arch Pharmalabs Recent Development
Table 98. SMS Pharmaceuticals Company Information
Table 99. SMS Pharmaceuticals Description and Business Overview
Table 100. SMS Pharmaceuticals Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 101. SMS Pharmaceuticals Valacyclovir API Product
Table 102. SMS Pharmaceuticals Recent Development
Table 103. Exemed PharmaceuticalsFDAWHO-GMP Company Information
Table 104. Exemed PharmaceuticalsFDAWHO-GMP Description and Business Overview
Table 105. Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 106. Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product
Table 107. Exemed PharmaceuticalsFDAWHO-GMP Recent Development
Table 108. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Company Information
Table 109. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Description and Business Overview
Table 110. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 111. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product
Table 112. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Development
Table 113. Piramal Pharma Solutions Company Information
Table 114. Piramal Pharma Solutions Description and Business Overview
Table 115. Piramal Pharma Solutions Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 116. Piramal Pharma Solutions Valacyclovir API Product
Table 117. Piramal Pharma Solutions Recent Development
Table 118. Rajasthan Antibiotics Company Information
Table 119. Rajasthan Antibiotics Description and Business Overview
Table 120. Rajasthan Antibiotics Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 121. Rajasthan Antibiotics Valacyclovir API Product
Table 122. Rajasthan Antibiotics Recent Development
Table 123. Vital Laboratories Private Limited Company Information
Table 124. Vital Laboratories Private Limited Description and Business Overview
Table 125. Vital Laboratories Private Limited Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 126. Vital Laboratories Private Limited Valacyclovir API Product
Table 127. Vital Laboratories Private Limited Recent Development
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Valacyclovir API Distributors List
Table 131. Valacyclovir API Customers List
Table 132. Valacyclovir API Market Trends
Table 133. Valacyclovir API Market Drivers
Table 134. Valacyclovir API Market Challenges
Table 135. Valacyclovir API Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Valacyclovir API Product Picture
Figure 2. Global Valacyclovir API Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Valacyclovir API Sales Market Share by Type in 2024 & 2031
Figure 4. Above 98 % Product Picture
Figure 5. Above 99 % Product Picture
Figure 6. Global Valacyclovir API Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Valacyclovir API Sales Market Share by Application in 2024 & 2031
Figure 8. Tablets Examples
Figure 9. Others Examples
Figure 10. Global Valacyclovir API Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Valacyclovir API Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Valacyclovir API Sales (Kg) Growth Rate (2020-2031)
Figure 13. Global Valacyclovir API Price Trends Growth Rate (2020-2031) & (US$/Kg)
Figure 14. Valacyclovir API Report Years Considered
Figure 15. Global Market Valacyclovir API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Valacyclovir API Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Valacyclovir API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Valacyclovir API Sales (Kg) Growth Rate (2020-2031)
Figure 19. Europe Valacyclovir API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Valacyclovir API Sales (Kg) Growth Rate (2020-2031)
Figure 21. China Valacyclovir API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Valacyclovir API Sales (Kg) Growth Rate (2020-2031)
Figure 23. Australia Valacyclovir API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Australia Valacyclovir API Sales (Kg) Growth Rate (2020-2031)
Figure 25. Israel Valacyclovir API Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Israel Valacyclovir API Sales (Kg) Growth Rate (2020-2031)
Figure 27. Global Valacyclovir API Revenue Share by Type (2020-2025)
Figure 28. Global Valacyclovir API Sales Share by Type (2026-2031)
Figure 29. Global Valacyclovir API Revenue Share by Type (2026-2031)
Figure 30. Global Valacyclovir API Revenue Share by Application (2020-2025)
Figure 31. Global Valacyclovir API Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Valacyclovir API Sales Share by Application (2026-2031)
Figure 33. Global Valacyclovir API Revenue Share by Application (2026-2031)
Figure 34. Global Valacyclovir API Sales Share by Company (2024)
Figure 35. Global Valacyclovir API Revenue Share by Company (2024)
Figure 36. Global 5 Largest Valacyclovir API Players Market Share by Revenue in Valacyclovir API: 2020 & 2024
Figure 37. Valacyclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Valacyclovir API
Figure 39. Manufacturing Process Analysis of Valacyclovir API
Figure 40. Valacyclovir API Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Valacyclovir API market?
The top companies in the global Valacyclovir API market are Mylan、NEWEDGE Overseas、Aurore Life Sciences.
Related Reports
Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
Global Valacyclovir API Market Research Report 2026
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 126
USD 2900.00
(Single User License)
Global Valacyclovir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 132
USD 4900.00
(Single User License)
Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 96
USD 3950.00
(Single User License)
Global Valacyclovir API Market Research Report 2025
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 92
USD 2900.00
(Single User License)
Global Valacyclovir API Market Research Report 2024
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published Date: 2024-02-07
Pages: 102
USD 2900.00
(Single User License)
Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 135
USD 3950.00 (Single User License)Global Valacyclovir API Market Research Report 2026
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 126
USD 2900.00 (Single User License)Global Valacyclovir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 132
USD 4900.00 (Single User License)Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 96
USD 3950.00 (Single User License)Global Valacyclovir API Market Research Report 2025
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 92
USD 2900.00 (Single User License)Global Valacyclovir API Market Research Report 2024
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published: 2024-02-07
Pages: 102
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now